Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


TSX:ATE - Post by User

Post by davgroon Aug 16, 2022 4:07pm
286 Views
Post# 34900404

Trading Update from the Dumpster

Trading Update from the DumpsterOur resident ATE troll "the Dumpster" was called in to work a day shift at the McDonald's Drive-Thru so he asked me to post an update for all board members on his recent ATE swing trade;

"What a boring ATE earnings report......ZZZzzzzzzz. That loser davgro knows nothing about flipping pennies.  I bought 500 shares of ATE yesterday at $.60 and caught the upswing today and sold at $.66.  Less my commissions and using my employee discount I was able to purchase a Happy meal, large Coke and Oreo McFlurry with my winfall.  Not a bad return on a $300 investment. Now who's the great trader eh davgro (aka Pez and 32 other aliases) ?  I will  probably buy back my 500 shares tomorrow at $.60 again.  Rinse, repeat."
<< Previous
Bullboard Posts
Next >>